Fuente: Cicouncil Lugar: Council news The latest Care Quality Commission (CQC) annual update on controlled drugs offers another encouraging snapshot of the continued development of the UK’s medical cannabis sector. Some of key takeaways include: A 2.3x increase in cannabis-based products for medicinal use (CBPMs) prescribed in the year to 31 March 2025, demonstrating continued growth in patient access. 63% […]
The post CQC Annual Report Highlights Continued Growth in UK Medical Cannabis Prescribing appeared first on Cannabis Industry Council.